Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT02645981 · COMPLETED
Trial details
- NCT number
- NCT02645981
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2019-11-27
- Enrollment
- 668
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.